why choose us

First received: February 18, 2023

Clinical Trial: ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Generalized Anxiety Disorder

Study Type: INTERVENTIONAL


Official Title: The ENCALM Trial: A Randomized, Double-blind, Placebo-controlled Monotherapy Trial to Evaluate the Efficacy and Safety of ENX-102 in Patients With Generalized Anxiety Disorder

Brief Summary: The ENCALM trial is designed to evaluate the efficacy and safety of ENX-102 in patients diagnosed with generalized anxiety disorder (GAD)

Read more